Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 1;318(5):L1023-L1024.
doi: 10.1152/ajplung.00118.2020.

Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19

Thomas Walther  1   2 , Wolfgang M Kuebler  3   4   5
Affiliations
Comment

Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19

Thomas Walther et al. Am J Physiol Lung Cell Mol Physiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

T.W. and W.M.K. are the inventors of the 2010 filed patent application “Use of an Ang-(1–7) receptor agonist in acute lung injury.”

Comment in

Comment on

References

    1. Abassi ZA, Skorecki K, Heyman SN, Kinaneh S, Armaly Z. Covid-19 infection and mortality: a physiologist’s perspective enlightening clinical features and plausible interventional strategies. Am J Physiol Lung Cell Mol Physiol. In press. doi:10.1152/ajplung.00097.2020. - DOI - PMC - PubMed
    1. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368: m1091, 2020. [Erratum in BMJ 368: m1295, 2020.] doi:10.1136/bmj.m1091. - DOI - PMC - PubMed
    1. Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. In press. doi:10.1161/HYPERTENSIONAHA.120.15082. - DOI - PMC - PubMed
    1. Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Liu HG. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). In press. doi:10.1097/CM9.0000000000000824. - DOI - PMC - PubMed
    1. European Medicines Agency . EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic (Online). EMA/143324/2020 [27 March 2020].

LinkOut - more resources